<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-22T07:57:45Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/1564DDAF-7DF1-41E8-ACC8-22E17D47E0E6" ns1:id="1564DDAF-7DF1-41E8-ACC8-22E17D47E0E6"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/233A5929-805E-4DED-B47F-01C893B1C7FF" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/E007DEFB-01FF-4A15-B972-1F105FF83666" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/E007DEFB-01FF-4A15-B972-1F105FF83666" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/C250D6E3-1555-439F-A0DD-889B0D113D01" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2013-12-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/AE577338-F5E5-4FD8-9175-47168A4A5844" ns1:rel="FUND" ns1:start="2013-01-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">130993</ns2:identifier></ns2:identifiers><ns2:title>Feasibility and market potential for expanding the SentiMag indication to sentinel lymph node biopsy in melanoma</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>The novel SentiMag magnetic dye and hand-held magnetometer technique has been successfully applied to the sentinel lymph node biopsy (SLNB) procedure in breast cancer. It overcomes the disadvantages of the current radioisotope based technique - including lack of availability, workflow and handling issues and exposure to radiation.
The benefits of this magnetic technique could potentially be applied to other cancers including malignant melanoma, a high profile cancer with more than 116,000 cases per year in the EU and US alone (WHO), and a rapidly increasing incidence.
This project will explore the clinical feasibility of applying magnetic SLN detection to melanoma.</ns2:abstractText></ns2:project>